Skip to main content

Table 2 Association between patient/tumor data and pCR in univariate

From: Significance of the neutrophil-to-lymphocyte ratio in predicting the response to neoadjuvant chemotherapy in extremity osteosarcoma: a multicentre retrospective study

Variable

n

pCR(%)

P value

Age (year)

  

0.669

≤17

56

22(39.3)

 

>17

40

14(35.0)

 

Sex

  

0.111

 Male

54

24(44.4)

 

 Female

42

12(28.6)

 

Tumor location

  

0.896

 Tibia

40

16(40.0)

 

 Femur

44

16(36.4)

 

 Others

12

4(33.3)

 

Tumor size (cm3)

  

0.034

  ≤ 195.37

38

20(52.6)

 

  > 195.37

58

18(31.0)

 

Enneking stage

  

0.023

 I

28

15(53.6)

 

 II

46

16(34.8)

 

 III

22

5(22.7)

 

Subtype

  

0.263

 Osteoblastic

58

23(39.7)

 

 Chondroblastic

22

6(27.3)

 

 Others

16

7(43.8)

 

Regimens of NACT

  

0.261

 AP

36

12(33.3)

 

 MAP

60

24(40.0)

 

ALP

  

0.342

 Elevated

50

21(42.0)

 

 Normal

46

15(32.6)

 

ESR

  

0.406

 Elevated

70

28(40.0)

 

 Normal

26

8(30.8)

 

CRP

  

0.592

 Elevated

64

25(39.1)

 

 Normal

32

11(34.4)

 

NLR

  

0.021

 LNLR

50

22(44.0)

 

 HNLR

46

14(30.4)

 

PLR

  

0.031

 LPLR

30

16(53.3)

 

 HPLR

66

20(30.3)